![Suresh Ramalingam tells us what it’s like to become director of Emory Cancer Center and editor of Cancer—on the same day](https://cdn.cancerletter.com/media/2021/07/09164506/47-27-peaches-4x3-1.jpg)
![Suresh Ramalingam tells us what it’s like to become director of Emory Cancer Center and editor of Cancer—on the same day](https://cdn.cancerletter.com/media/2021/07/09164506/47-27-peaches-4x3-1.jpg)
Cover Story
Conversation with The Cancer Letter
It’s safe to say that July 1 was a better than average day for Suresh S. Ramalingam.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
Drugs & Targets
Trending Stories
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission